Latest News
CDC, the UK’s Development Finance Institution, has announced a USD30 million investment in the African Infrastructure Investment Fund 2 (AIIF2), an equity investment fund committed to developing basic infrastructure in Africa.
CDC’s USD30m commitment will help AIIF2 move closer to its target size of USD600m, which it will use to invest in a range of new and existing transport and power infrastructure projects such as toll roads, ports and rail, wind farms and other forms of renewable and traditional energy.
AIIF2 is managed by Africa Infrastructure Investment Managers (AIIM), a highly regarded team which has considerable experience of infrastructure
Leading mid-market private equity firm LDC has backed the expansion of eConveyancer, a fast growing provider of software for online conveyancing and home buyer search services, with a significant injection of development capital.
Oxfordshire-based eConveyancer, established in 2003, currently has a two per cent share of the UK online conveyancing market and has recently secured contracts which will result in its market share rising to 10 per cent over the next two years.
Its conveyancing software allows mortgage applicants, mortgage lenders, financial advisors and estate agents to search for and instruct a conveyancer online, comparing prices and tracking a
LLR Partners, a leading middle market private equity firm with more than USD1.4 billion under management, has announced four additions to the firm. Jack Slye joins LLR as a Vice President, Irene Lisyansky and Brian Berkin come on as Senior Associates, and Scott Williams will serve as a Senior Analyst.
“We are very fortunate to continue to attract experienced, bright talent to the LLR team,” says Mitchell Hollin (pictured), Partner at LLR Partners. “Most importantly, our new colleagues will add to the collaborative culture we have created. As our investment activity increases, we are eager to capitalize on their knowledge
Bunker Hill Capital, a lower middle market buyout fund, has had a final closing on commitments totalling USD200 million for its second fund, Bunker Hill Capital II. New investors in the second fund included a diverse group of limited partners, both domestic and international.
“We are thrilled to have such a strong and diverse group of new limited partners in addition to existing investors from Fund I,” says Mark DeBlois, a Managing Partner of Bunker Hill. “We are very appreciative of the ongoing support from our limited partners,” adds Rufus Clark, also a Managing Partner.
“We invested with Bunker Hill
Cloud gaming company Playcast Media Systems has raised USD10 million in Series B financing from MK Capital, a Chicago/Los Angeles-based venture fund specialising in digital media, and JVP, a leading Israeli venture capital firm focused on media, technology and content.
Existing shareholders Xenia Venture Capital and C.Mer Industries also participated in the round. Playcast, a provider of AAA quality video-game streaming channels to multi-system operators (MSOs) and telecommunication companies, launched its initial European service in November of last year.
Along with the investment, Playcast has also appointed to its Board of Directors Gadi Tirosh, a JVP partner and a former
Thames River has strengthened its property team with the appointment of Raymond Lahaut as manager of the Longstone long/short real estate equity fund.
Since its launch in November 2007, Longstone has grown by 23.65% (figures from 30.11.07 to 31.12.10, for euro share class), a period in which the Dow Jones Credit Suisse Long/Short Equity Hedge Fund Index rose by only 3.7% and EPRA, an index of European listed real estate securities, fell by 32.4%.
Lahaut has been managing portfolios of property securities since 1999, first with Insinger de Beaufort and later at Ohra Asset Management (part of the
Independence Equity Management has launched Independence Equity I LP, a venture capital fund that will invest in early-stage companies commercialising technologies that improve resource utilisation.
Today’s announcement follows the first close of capital for the new fund, which will begin making investments this year. A second close is tentatively scheduled for April 30, 2011.
The fund’s principals define resource utilisation as the use or consumption of resources such as raw materials and labor. The objective is to identify innovations in business processes and technologies that reduce raw material consumption, improve yield/performance, increase labor efficiency or enable point-of-use production. The
Stephen C Massanelli has rejoined Dallas-based private investment firm Treadstone Partners as a Principal.
”The return of Steve to our leadership team is an important step in positioning the firm going forward,” says Phil Dixon, President. “With his background, he will be actively involved in all stages of the investment process and will have a particular focus on the firm’s future funding strategy.”
Massanelli was most recently Senior Vice President and Treasurer for Zale Corporation (NYSE: ZLC). During his 10-plus years at Zale, Massanelli held responsibility for finance/treasury, real estate, IT, risk management and credit operations. During the past year,
The total value of european private equity deals in 2010 totalled EUR71.5bn, and increase of 143 per cent on 2009, according to Candover’s latest Private Equity Barometer.
In the final quarter of 2010 there were 230 private equity-backed deals recorded with a value of EUR22bn, slightly down on the 235 recorded in the same quarter of 2009, but up 50% from EUR10.3bn in value terms.
The total number of buyouts increased for the third consecutive quarter, with Q4’s 101 deals making it the best performing quarter in 18 months in volume terms, and up 31% on the 77 buyouts recorded
Amgen is to acquire BioVex Inc a portfolio company of Forbion Capital Partners. Biovex Group is a privately held biotechnology company that has two biologics in clinical development, including Biovex’s lead product candidate, OncoVEXGM-CSF, a first in class oncolytic vaccine that may prove to be a paradigm-shifting approach to treating melanoma and other solid tumors, as well as a vaccine for genital herpes.
The transaction has been approved by the boards of directors of each company. It is subject to customary closing conditions, including regulatory approvals, and is expected to close in the first quarter of 2011.
Under terms
Special Reports
Featured
- Insight
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
